EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Oral Microbiome Biomarkers Associated with Lung Cancer Diagnosis and Radiotherapy Response Prediction

Xiaoqian Shi, Nan Bi, Wenyang Liu, Liying Ma, Mingyang Liu, Tongzhen Xu, Xingmei Shu, Linrui Gao, Ranjiaxi Wang, Yinan Chen, Li Li, Yu Zhu und 1 weitere

Pathogens · 2025

DOI: 10.3390/pathogens14121294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Xiaoqian Shi und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of M…. Hauptthemen laut MEDLINE: Microbiota, Lung Neoplasms, Mouth, Bacteria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National High Level Hospital Clinical Research Funding and National Cancer Center Climbing Fund, Noncommunicable Chronic Diseases-National Science and Technology Major Project, National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The oral cavity acts as the anatomical gateway to the respiratory tract, sharing both microbiological and pathophysiological links with the lower airways. Although radiotherapy is a cornerstone treatment for lung cancer, reliable oral microbiome biomarkers for predicting patient outcomes remain lacking. We analyzed the oral microbiome of 136 lung cancer patients and 199 healthy controls across discovery and two validation cohorts via 16S rRNA sequencing. Healthy controls exhibited a significantly higher abundance of Streptococcus compared to patients (p = 0.049, p < 0.001, p < 0.001, respectively). The structure of the microbial community exhibited substantial dynamic changes during treatment. Responders showed enrichment of Rothia aeria (p = 0.027) and Prevotella salivae (p = 0.043), associated with prolonged overall survival (OS) and progression-free survival (PFS), whereas non-responders exhibited elevated Porphyromonas endodontalis (p = 0.037) correlating with shorter OS and PFS. According to Analysis of Compositions of Microbiomes with Bias Correction 2 (ANCOM-BC2) analysis, Akkermansia and Alistipes were nearly absent in non-responders, while Desulfovibrio and Moraxella were virtually absent in responders. A diagnostic model based on Streptococcus achieved area under the curve (AUC) values of 0.85 (95% CI: 0.78–0.91) and 0.99 (95% CI: 0.98–1) in the validation cohorts, and a response prediction model incorporating Prevotella salivae and Neisseria oralis yielded an AUC of 0.74 (95% CI: 0.58–0.90). Furthermore, in small cell lung cancer, microbiota richness and diversity were inversely correlated with Eastern Cooperative Oncology Group (ECOG) performance status (p = 0.008, p < 0.001, respectively) and pro-gastrin-releasing peptide (ProGRP) levels (p = 0.065, p = 0.084, respectively). These results demonstrate that lung cancer-associated oral microbiota signatures dynamically reflect therapeutic response and survival outcomes, supporting their potential role as non-invasive biomarkers for diagnosis and prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrobiotaLung NeoplasmsMouthBacteriaHumansMaleFemaleMiddle AgedRNA, Ribosomal, 16SAgedBiomarkersPrognosisBiomarkers, Tumor

Stichwörter der Autor:innen

diagnostic modellung canceroral microbiotaradiotherapytreatment response prediction

Substanzen

RNA, Ribosomal, 16SBiomarkersBiomarkers, Tumor

Autor:innen und Institutionen

  • State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, Chin…
  • Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Department of Clinical Laboratory, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Laboratory Animal Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

ORCID-Profile: Dan Li

Förderung

  • National High Level Hospital Clinical Research Funding and National Cancer Center Climbing Fund
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Shi, X., Bi, N., Liu, W., Ma, L., Liu, M., Xu, T., Shu, X., Gao, L., Wang, R., Chen, Y., Li, L., Zhu, Y., & Li, D. (2025). Identification of Oral Microbiome Biomarkers Associated with Lung Cancer Diagnosis and Radiotherapy Response Prediction. Pathogens. https://doi.org/10.3390/pathogens14121294

Vancouver

Shi X, Bi N, Liu W, Ma L, Liu M, Xu T, et al. Identification of Oral Microbiome Biomarkers Associated with Lung Cancer Diagnosis and Radiotherapy Response Prediction. Pathogens. 2025. doi:10.3390/pathogens14121294

BibTeX
@article{Shi2025,
  author = {Shi, Xiaoqian and Bi, Nan and Liu, Wenyang and Ma, Liying and Liu, Mingyang and Xu, Tongzhen and Shu, Xingmei and Gao, Linrui and Wang, Ranjiaxi and Chen, Yinan and Li, Li and Zhu, Yu and Li, Dan},
  title = {Identification of Oral Microbiome Biomarkers Associated with Lung Cancer Diagnosis and Radiotherapy Response Prediction},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14121294}
}
Kostenlos starten →